Sentinel lymph node biopsy in operations for recurrent breast cancer
(2008) In European Journal of Surgical Oncology 34(6). p.626-630- Abstract
- Background: In a pilot prospective consecutive series on 50 patients with recurrent breast cancer, results of sentinel lymph node biopsy (SLNB) are reported. The interval between primary operation and recurrence was 8 years (range 1-18 years). Only three patients had not undergone dissection of the axilla (ALND). Results: In 51% of patients scintigraphy disclosed sentinel nodes (SN). At operation SN was identified in 45% of patients corresponding to 83% of the SN's visualized by the scintigraphy. SN contained metastases in seven cases (16%), and the treatment plan was changed as a consequence of the SN examination. Conclusion: SLNB can identify SN at a high rate, and the findings may influence further planning of treatment. SLNB should be... (More)
- Background: In a pilot prospective consecutive series on 50 patients with recurrent breast cancer, results of sentinel lymph node biopsy (SLNB) are reported. The interval between primary operation and recurrence was 8 years (range 1-18 years). Only three patients had not undergone dissection of the axilla (ALND). Results: In 51% of patients scintigraphy disclosed sentinel nodes (SN). At operation SN was identified in 45% of patients corresponding to 83% of the SN's visualized by the scintigraphy. SN contained metastases in seven cases (16%), and the treatment plan was changed as a consequence of the SN examination. Conclusion: SLNB can identify SN at a high rate, and the findings may influence further planning of treatment. SLNB should be a future standard procedure in operations for recurrent breast cancer. Next step should be a randomized study. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/1191087
- author
- Axelsson, C K and Jönsson, Per-Ebbe LU
- organization
- publishing date
- 2008
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- surgery, scintigraphy, recurrence, sentinel node, breast cancer
- in
- European Journal of Surgical Oncology
- volume
- 34
- issue
- 6
- pages
- 626 - 630
- publisher
- Elsevier
- external identifiers
-
- wos:000256812400004
- scopus:43449092239
- pmid:18029134
- ISSN
- 1532-2157
- DOI
- 10.1016/j.ejso.2007.09.004
- language
- English
- LU publication?
- yes
- id
- 68f8d151-2bed-482b-bb04-8a88a28c6b0c (old id 1191087)
- date added to LUP
- 2016-04-01 12:17:52
- date last changed
- 2022-02-26 05:11:36
@article{68f8d151-2bed-482b-bb04-8a88a28c6b0c,
abstract = {{Background: In a pilot prospective consecutive series on 50 patients with recurrent breast cancer, results of sentinel lymph node biopsy (SLNB) are reported. The interval between primary operation and recurrence was 8 years (range 1-18 years). Only three patients had not undergone dissection of the axilla (ALND). Results: In 51% of patients scintigraphy disclosed sentinel nodes (SN). At operation SN was identified in 45% of patients corresponding to 83% of the SN's visualized by the scintigraphy. SN contained metastases in seven cases (16%), and the treatment plan was changed as a consequence of the SN examination. Conclusion: SLNB can identify SN at a high rate, and the findings may influence further planning of treatment. SLNB should be a future standard procedure in operations for recurrent breast cancer. Next step should be a randomized study.}},
author = {{Axelsson, C K and Jönsson, Per-Ebbe}},
issn = {{1532-2157}},
keywords = {{surgery; scintigraphy; recurrence; sentinel node; breast cancer}},
language = {{eng}},
number = {{6}},
pages = {{626--630}},
publisher = {{Elsevier}},
series = {{European Journal of Surgical Oncology}},
title = {{Sentinel lymph node biopsy in operations for recurrent breast cancer}},
url = {{http://dx.doi.org/10.1016/j.ejso.2007.09.004}},
doi = {{10.1016/j.ejso.2007.09.004}},
volume = {{34}},
year = {{2008}},
}